Clinical Trial Update: Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel and S-1 followed by radiation therapy and low-dose cisplatin in patients with stage III or IV head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN